Keros Therapeutics shares owned by Legal & General Group
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Legal & General Group
from 13F filings
Historical chart of Legal & General Group investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Keros Therapeutics by Legal & General Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $751k | 19k | 39.76 |
2023-09-30 | $603k | 19k | 31.88 |
2023-06-30 | $727k | 18k | 40.18 |
2023-03-31 | $408k | 9.5k | 42.70 |
2022-12-31 | $388k | 8.1k | 48.02 |
2022-09-30 | $287k | 7.6k | 37.53 |
2022-06-30 | $191k | 6.9k | 27.66 |
2022-03-31 | $373k | 6.9k | 54.46 |
2021-12-31 | $360k | 6.2k | 58.46 |
2021-09-30 | $243k | 6.1k | 39.59 |
2021-06-30 | $154k | 3.6k | 42.45 |
2021-03-31 | $211k | 3.4k | 61.81 |
2020-12-31 | $245k | 3.5k | 70.48 |
2020-09-30 | $32k | 838 | 38.19 |
2020-06-30 | $42k | 1.1k | 37.23 |